Selection of effective antisense oligodeoxynucleotides with a green fluorescent protein-based assay -: Discovery of selective and potent inhibitors of glutathione S-transferase Mu expression

被引:7
作者
't Hoen, PAC
Rosema, BS
Commandeur, JNM
Vermeulen, NPE
Manoharan, M
van Berkel, TJC
Biessen, EAL
Bijsterbosch, MK
机构
[1] Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, NL-2300 RA Leiden, Netherlands
[2] Leiden Amsterdam Ctr Drug Res, Div Mol Toxicol, NL-2300 RA Leiden, Netherlands
[3] ISIS Pharmaceut, Carlsbad, CA 92008 USA
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2002年 / 269卷 / 10期
关键词
antisense oligodeoxynucleotide; carcinogenesis; genetic polymorphism; glutathione S-transferase; green fluorescent protein;
D O I
10.1046/j.1432-1033.2002.02924.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antisense oligodeoxynucleotides (AS-ODNs) are frequently used for the down-regulation of protein expression. Because the majority of potential antisense sequences lacks effectiveness, fast screening methods for the selection of effective AS-ODNs are needed. We describe a new cellular screening assay for the evaluation of the potency and specificity of new antisense sequences. Fusion constructs of the gene of interest and the gene encoding the enhanced green fluorescent protein (EGFP) are cotransfected with AS-ODNs to COS-7 cells. Subsequently, cells are analysed for expression of the EGFP fusion protein by flow cytometry. With the assay, we tested the effectiveness of a set of 15 phosphorothioate ODNs against rat glutathione S -transferase Mu1 (GSTM1) and/or Mu2 (GSTM2). We found several AS-ODNs that demonstrated potent, sequence-specific, and concentration-dependent inhibition of fusion protein expression. At 0.5 muM, AS-6 and AS-8 inhibited EGFP-GSTM1 expression by 95 +/- 4% and 81 +/- 6%, respectively. AS-5 and AS-10 were selective for GSTM2 (82 +/- 4% and 85 +/- 0.4% decrease, respectively). AS-2 and AS-3, targeted at homologous regions in GSTM1 and GSTM2, inhibited both isoforms (77-95% decrease). Other AS-ODNs were not effective or displayed non-target-specific inhibition of protein expression. The observed decrease in EGFP expression was accompanied by a decrease in GSTM enzyme activity. As isoform-selective, chemical inhibitors of GSTM and GSTM knock-out mice are presently unavailable, the selected AS-ODNs constitute important tools for the study of the role of GSTM in detoxification of xenobiotics and protection against chemical-induced carcinogenesis.
引用
收藏
页码:2574 / 2583
页数:10
相关论文
共 33 条
[1]  
Agrawal Sudhir, 1995, Current Opinion in Biotechnology, V6, P12, DOI 10.1016/0958-1669(95)80003-4
[2]   Modulation of plasma protein binding and in vivo liver cell uptake of phosphorothioate oligodeoxynucleotides by cholesterol conjugation [J].
Bijsterbosch, MK ;
Rump, ET ;
De Vrueh, RLA ;
Dorland, R ;
van Veghel, R ;
Tivel, KL ;
Biessen, EAL ;
van Berkel, TJC ;
Manoharan, M .
NUCLEIC ACIDS RESEARCH, 2000, 28 (14) :2717-2725
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]  
BROWN DA, 1994, J BIOL CHEM, V269, P26801
[5]  
COMMANDEUR JNM, 1995, PHARMACOL REV, V47, P271
[6]   Optimal lipofection reagent varies with the molecular modifications of the DNA [J].
Conrad, AH ;
Behlke, MA ;
Jaffredo, T ;
Conrad, GW .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1998, 8 (05) :427-434
[7]   Progress in antisense oligonucleotide therapeutic [J].
Crooke, ST ;
Bennett, CF .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 :107-129
[8]  
DEAN NM, 1994, J BIOL CHEM, V269, P16416
[9]   Potent and selective gene inhibition using antisense oligodeoxynucleotides [J].
Flanagan, WM ;
Wagner, RW .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1997, 172 (1-2) :213-225
[10]  
Galderisi U, 1999, J CELL PHYSIOL, V181, P251, DOI 10.1002/(SICI)1097-4652(199911)181:2<251::AID-JCP7>3.0.CO